
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Dr. Sidarta Ribeiro, Deputy Director of the Brain Institute at the Unversidade Federal do Rio Grande do Norte in Brazil. His book is “The Oracle of Night … The History and Science of Dreams”. Then, a potential new treatment for a side effect of chemotherapy: Hand-Foot Skin Reaction and Hand-Foot Syndrome. Dr. Michael McCullar, the CEO of OnQuality Pharmaceuticals talks about their new drug candidate which has just finished Phase II clinical trials.
By Tech Nation4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Dr. Sidarta Ribeiro, Deputy Director of the Brain Institute at the Unversidade Federal do Rio Grande do Norte in Brazil. His book is “The Oracle of Night … The History and Science of Dreams”. Then, a potential new treatment for a side effect of chemotherapy: Hand-Foot Skin Reaction and Hand-Foot Syndrome. Dr. Michael McCullar, the CEO of OnQuality Pharmaceuticals talks about their new drug candidate which has just finished Phase II clinical trials.

21,954 Listeners

43,837 Listeners

32,246 Listeners

38,430 Listeners

6,881 Listeners

43,687 Listeners

27,011 Listeners

2,891 Listeners

9,238 Listeners

467 Listeners

736 Listeners

935 Listeners

6,467 Listeners

941 Listeners

33 Listeners